Ocular penetration of fluorometholone-loaded PEG-PLGA nanoparticles functionalized with cell-penetrating peptides

dc.contributor.authorGonzález Pizarro, Roberto Carlos
dc.contributor.authorParrotta, Graziella
dc.contributor.authorVera-García, Rodrigo
dc.contributor.authorSánchez-López, E. (Elena)
dc.contributor.authorGalindo Camacho, Ruth Milagros
dc.contributor.authorKjeldsen, Frank
dc.contributor.authorBadía Palacín, Josefa
dc.contributor.authorBaldomà Llavinés, Laura
dc.contributor.authorEspina García, Marta
dc.contributor.authorGarcía López, María Luisa
dc.date.accessioned2020-06-04T07:37:28Z
dc.date.available2020-11-26T06:10:20Z
dc.date.issued2019-11-26
dc.date.updated2020-06-04T07:37:29Z
dc.description.abstractAim: Development of fluorometholone-loaded PEG-PLGA nanoparticles (NPs) functionalized with cellpenetrating peptides for the treatment of ocular inflammatory disorders. Materials & methods: Synthesized polymers and peptides were used for elaboration of functionalized NPs, which were characterized physicochemically. Cytotoxicity and ability to modulate the expression of proinflammatory cytokines were evaluated in vitro using human corneal epithelial cells (HCE-2). NP uptake was assayed in both in vitro and in vivo models. Results: NPs showed physicochemical characteristics suitable for ocular administration without evidence of cytotoxicity. TAT-NPs and G2-NPs were internalized and displayed anti-inflammatory activity in both HCE-2 cells and mouse eye. Conclusion: TAT-NPs and G2-NPs could be considered a novel strategy for the treatment of ocular inflammatory diseases of the anterior and posterior segment.
dc.format.extent16 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec694447
dc.identifier.issn1743-5889
dc.identifier.urihttps://hdl.handle.net/2445/164191
dc.language.isoeng
dc.publisherFuture Medicine
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.2217/nnm-2019-0201
dc.relation.ispartofNanomedicine, 2019, vol. 14, num. 23, p. 3089-3104
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/646603/EU//METALS
dc.relation.urihttps://doi.org/10.2217/nnm-2019-0201
dc.rights(c) Future Medicine, 2019
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Bioquímica i Fisiologia)
dc.subject.classificationFarmacologia ocular
dc.subject.classificationAgents antiinflamatoris
dc.subject.classificationSistemes d'alliberament de medicaments
dc.subject.classificationNanopartícules
dc.subject.classificationUveïtis
dc.subject.classificationPolímers
dc.subject.classificationPèptids
dc.subject.otherOcular pharmacology
dc.subject.otherAntiinflammatory agents
dc.subject.otherDrug delivery systems
dc.subject.otherNanoparticles
dc.subject.otherUveitis
dc.subject.otherPolymers
dc.subject.otherPeptides
dc.titleOcular penetration of fluorometholone-loaded PEG-PLGA nanoparticles functionalized with cell-penetrating peptides
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
694447.pdf
Mida:
7.31 MB
Format:
Adobe Portable Document Format